Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.
Press releases published on May 6, 2025
Zanda Earns Spot on G2’s 2025 Best Software Awards for Best Healthcare Software Products
EIN Presswire
·
May 6, 2025
Zanda, a global practice management software company, has been named in G2’s 2025 Best Software Awards. SALT LAKE CITY, UT, UNITED STATES, May 6, 2025 /EINPresswire.com/ -- Zanda, a global practice management software company, today announced it has …
Healthcare in India Set for a Major Overhaul with The Rescue Federation®’s Latest Projects
EIN Presswire
·
May 6, 2025
The Rescue Federation® is launching two key projects to make emergency help faster and teach people basic life-saving skills. NEW DELHI, DELHI, INDIA, May 6, 2025 /EINPresswire.com/ -- The Rescue Federation®, a leading provider of air, rail, road …
Eupraxia Pharmaceuticals Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 6, 2025
Data from Phase 1b/2a RESOLVE suggests EP-104GI has significant potential to improve the standard of care for patients with Eosinophilic Esophagitis (EoE) Cash runway to fund operations out to third quarter of 2026 Company to host webinar to discuss …
Dunham House Breaks Ground on Transformational Housing for Combat-Wounded Veterans
GlobeNewswire
·
May 6, 2025
OMAHA, Neb., May 06, 2025 (GLOBE NEWSWIRE) -- Between 2000 and 2019, the Defense and Veterans Brain Injury Center reported nearly 414,000 service members worldwide sustained a traumatic brain injury. In the same period, estimates suggest that between 9% …
WeightWatchers Takes Strategic Action to Eliminate $1.15 Billion of Debt, Strengthening Financial Position for Long-Term Growth and Profitability
GlobeNewswire
·
May 6, 2025
Operations continue with no impact to its more than three million members worldwide Positions the Company to execute its transformation strategy, focused on enhancing its digital and member experience and expanding its telehealth business which achieved …
BetterLife Announces Debt Settlements
GlobeNewswire
·
May 6, 2025
VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic …
WW International, Inc. Schedules Investor Conference Call
GlobeNewswire
·
May 6, 2025
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, announced that it will host an investor conference call today May 6, 2025, at 6:00 p. …
Cellectis to Report First Quarter Financial Results on May 12, 2025
GlobeNewswire
·
May 6, 2025
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced …
Jin Medical International Ltd. – Nasdaq Minimum Bid Price Non-Compliance
GlobeNewswire
·
May 6, 2025
Changzhou City, China, May 06, 2025 (GLOBE NEWSWIRE) -- Jin Medical International Ltd. (NASDAQ: ZJYL) (the “Company”) today announced that on May 2, 2025, it received a deficiency letter (the “Notice”) from the Nasdaq Listing Qualifications Department (the …
SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025
GlobeNewswire
·
May 6, 2025
SANTA CLARA, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming 2025 BofA Securities Healthcare …
Myriad Genetics Reports First Quarter 2025 Financial Results; Updates 2025 Financial Guidance
GlobeNewswire
·
May 6, 2025
Highlights First quarter 2025 revenue of $196 million declined by 3% year-over-year. Excluding headwinds1 of $16 million, revenue increased 5% year-over-year. First quarter 2025 Prenatal revenue grew 11% year-over-year, while Pharmacogenomics revenue …
Amwell makes grant to new employee under inducement plan
GlobeNewswire
·
May 6, 2025
BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading technology-enabled care platform provider, announced that on May 6, Amwell made a grant of RSUs of 3,451 shares of its Class A common stock to one new employee. The grant was offered …
BioAtla Reports First Quarter 2025 Financial Results and Highlights Recent Progress
GlobeNewswire
·
May 6, 2025
CAB-EpCAM x CAB-CD3 (BA3182) Phase 1 dose-escalation study ongoing, dosed first three patients at 300 micrograms; data readout expected mid-2025 with dose expansion data readout anticipated 1H 2026 Mecbotamab vedotin (Mec-V; CAB-AXL-ADC) continues to …
Clover Health Reports First Quarter 2025 Results and Improves Full Year 2025 Guidance
GlobeNewswire
·
May 6, 2025
First quarter 2025 Medicare Advantage membership of 103,418, up 30% year-over-year First quarter 2025 Total revenues of $462 million, up 33% year-over-year Medicare Advantage medical costs are in line with expectations, underscoring the strength of Clover’ …
Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025
GlobeNewswire
·
May 6, 2025
IRVINE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended March 31, 2025 and raised its …
Voyager Reports First Quarter 2025 Financial and Operating Results
GlobeNewswire
·
May 6, 2025
– Tau silencing gene therapy VY1706 to be featured in oral presentation at ASGCT 2025; has shown up to 73% knockdown of tau mRNA in the CNS in NHPs following a single IV dose of 1.3e13 vg/kg – – Recent Voyager data on VY7523 and VY1706 presented at AD/PD™ …
Lyra Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 6, 2025
WATERTOWN, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing long-acting, anti-inflammatory sinonasal implants for the treatment of chronic …
Ultragenyx Reports First Quarter 2025 Financial Results and Corporate Update
GlobeNewswire
·
May 6, 2025
First quarter total revenue of $139 million, Crysvita® revenue of $103 million and Dojolvi® revenue of $17 million Reaffirm 2025 Financial Guidance: Total revenue between $640 million to $670 million, Crysvita revenue of $460 million to $480 million, and …
Day One Reports First Quarter 2025 Financial Results and Corporate Progress
GlobeNewswire
·
May 6, 2025
OJEMDA™ (tovorafenib) prescriptions grew 16% in Q1 2025 compared to Q4 2024 Achieved Q1 2025 OJEMDA™ (tovorafenib) net product revenue of $30.5 million Ended the first quarter with $473.0 million in cash, cash equivalents and short-term investments Company …
Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025
GlobeNewswire
·
May 6, 2025
NEWTON, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the …